Select Medical faces a challenging outlook characterized by significant revenue volatility and structural margin compression, as evidenced by gross margins struggling to sustain levels above 13%. While the company has successfully reduced its debt-to-equity ra...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q2 2026Latest Apr 30, 2026 | $0.36-16.3% vs $0.43 | $1.4B+0.7% vs $1.4B |
Q1 2026 Feb 19, 2026 | $0.16-30.4% vs $0.23 | $1.4B+2.4% vs $1.4B |
Q4 2025 Oct 30, 2025 | $0.23+27.8% vs $0.18 | $1.4B+2.5% vs $1.3B |
Q3 2025 Jul 31, 2025 | $0.32+14.3% vs $0.28 | $1.3B-0.3% vs $1.3B |
MECHANICSBURG, Pa., June 30, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (the "Company" or "Select Medical," "we," "us," or "our") (NYSE: SEM) today announced the completion of its acquisition by an entity affiliated with a consortium led by Robert A.
MECHANICSBURG, Pa., June 26, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (NYSE: SEM) ("Select Medical," "we," "us," or "our") confirmed today that its previously announced Agreement and Plan of Merger (the "Merger Agreement," and the transaction contemplated thereby, the "Merger") with an entity affiliated with a consortium led by Robert A.
Benchmark SEM against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Select Medical Holdings Corporation (SEM)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $16.51 | $2.05B | 13.99 | 5.12% | 2.68% | 7.25% | 1.54% | |
| $176.32 | $10.28B | 30.19 | 18.72% | 6.9% | 16.51% | — | |
| $29.37 | $2.73B | -2.42 | 5.04% | -33.44% | -46.01% | — | |
| $179.29 | $10.85B | 7.76 | 9.71% | 8.42% | 20.37% | — | |
| $15.80 | $2.07B | -25.90 | 6.24% | -2.63% | -2.59% | — | |
| $438.12 | $94.85B | 15.44 | 7.08% | 8.77% | — | — |
Select Medical Holdings Corporation (SEM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Select Medical Holdings Corporation (SEM) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 1, 2026·SEC
Jun 26, 2026·SEC
Jun 22, 2026·SEC
Get notified when SEM posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Select Medical Holdings Corporation (SEM) stock FAQ — growth, dividends, profitability & financials explained
Select Medical Holdings Corporation (SEM) reported $5.52B in revenue for fiscal year 2025. This represents a 197% increase from $1.86B in 2005.
Select Medical Holdings Corporation (SEM) grew revenue by 5.1% over the past year. This is steady growth.
Yes, Select Medical Holdings Corporation (SEM) is profitable, generating $133.5M in net income for fiscal year 2025 (2.7% net margin).
Yes, Select Medical Holdings Corporation (SEM) pays a dividend with a yield of 1.54%. This makes it attractive for income-focused investors.
Select Medical Holdings Corporation (SEM) has a return on equity (ROE) of 7.3%. This is below average, suggesting room for improvement.
Select Medical Holdings Corporation (SEM) generated $117.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
